Early Detection of Peripheral Blood Cell Signature in Children Developing β-Cell Autoimmunity at a Young Age

Author:

Kallionpää Henna1,Somani Juhi2,Tuomela Soile1,Ullah Ubaid1ORCID,de Albuquerque Rafael1,Lönnberg Tapio1,Komsi Elina1,Siljander Heli34,Honkanen Jarno34,Härkönen Taina34,Peet Aleksandr56,Tillmann Vallo56,Chandra Vikash37,Anagandula Mahesh Kumar8,Frisk Gun8,Otonkoski Timo37ORCID,Rasool Omid1,Lund Riikka1,Lähdesmäki Harri2,Knip Mikael34910ORCID,Lahesmaa Riitta1ORCID

Affiliation:

1. Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland

2. Department of Computer Science, Aalto University School of Science, Espoo, Finland

3. Children’s Hospital, University of Helsinki, and Helsinki University Hospital, Helsinki, Finland

4. Research Programs Unit, Diabetes and Obesity, University of Helsinki, Helsinki, Finland

5. Department of Pediatrics, University of Tartu, Tartu, Estonia

6. Children’s Clinic of Tartu, Tartu University Hospital, Tartu, Estonia

7. Research Programs Unit, Molecular Neurology and Biomedicum Stem Cell Centre, Faculty of Medicine, University of Helsinki, Helsinki, Finland

8. Department of Immunology, Genetics and Pathology, Uppsala University, Sweden

9. Folkhälsan Research Center, Helsinki, Finland

10. Tampere Center for Child Health Research, Tampere University Hospital, Tampere, Finland

Abstract

The appearance of type 1 diabetes (T1D)-associated autoantibodies is the first and only measurable parameter to predict progression toward T1D in genetically susceptible individuals. However, autoantibodies indicate an active autoimmune reaction, wherein the immune tolerance is already broken. Therefore, there is a clear and urgent need for new biomarkers that predict the onset of the autoimmune reaction preceding autoantibody positivity or reflect progressive β-cell destruction. Here we report the mRNA sequencing–based analysis of 306 samples including fractionated samples of CD4+ and CD8+ T cells as well as CD4−CD8− cell fractions and unfractionated peripheral blood mononuclear cell samples longitudinally collected from seven children who developed β-cell autoimmunity (case subjects) at a young age and matched control subjects. We identified transcripts, including interleukin 32 (IL32), that were upregulated before T1D-associated autoantibodies appeared. Single-cell RNA sequencing studies revealed that high IL32 in case samples was contributed mainly by activated T cells and NK cells. Further, we showed that IL32 expression can be induced by a virus and cytokines in pancreatic islets and β-cells, respectively. The results provide a basis for early detection of aberrations in the immune system function before T1D and suggest a potential role for IL32 in the pathogenesis of T1D.

Funder

JDRF

Academy of Finland

Sigrid Jusélius Foundation

Diabetes Research Foundation

Novo Nordisk Foundation

Seventh Framework Programme

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3